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Abstract 
Objective: Congenital heart disease (CHD) is the most common congenital anomaly in 
newborns. The aim of this longitudinal, hospital-based study was to evaluate the prevalence 
and pattern of CHD among Iranian newborns in Gorgan, Northern Iran. 
Methods: 11739 live births in Dezyani hospital in Gorgan were screened for CHD, 2007 through 
2008. Clinical examination, echocardiography, color Doppler and cardio catheterization were 
used as diagnostic tools. Clinical and demographic factors, namely sex, type of CHD and 
associated anomalies of diagnosed cases were recorded in a pre-designed questionnaire for 
analysis. 
Findings: The overall prevalence rate of CHD was 8.6 per 1000 live births. This was 9.96 per 
1000 male births and 7.34 per 1000 female births. It was 4.5 and 13.19 per 1000 in 2007 and 
2008, respectively. ASD was the commonest lesion (2.64 per 1000), followed by VSD+ASD (1.28 
per 1000) and PDA (1.28 per 1000). The rate of ASD in male and female was 3.02 and 2.26 per 
1000 respectively. Parents of 40 (39.6%) babies were related. 39 (38.6%) couples were first 
cousins. 
Conclusion: This study showed that the prevalence of CHD among live births in Gorgan is lower 
than reported in the studies for Middle East and European countries. 
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Introduction 
Congenital heart disease (CHD) is the most 
common congenital anomaly in newborns. Also 
it is a leading cause of death during the first year  
of life with a prevalence of 1% in live births [1]. 
Etiology of CHD is multifactorial and a large 
collection of environmental and genetic 
causes have a role in its pathogenesis[2].    
Original Article Iran J Pediatr Sep 2011; Vol 21 (No 3), Pp: 307-312 
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     Malformations of the cardiovascular system 
are also associated with significant medical 
morbidity, which requires use of costly medical 
facilities [3]. Thus, determining the prevalence 
and pattern of CHD is necessary to recommend 
valuable changes in health policies [4]. CHDs are 
relatively common with a prevalence ranging 
from 3.7 to 17.5 per 1000 live births [3,4]. 
     Several previous reports suggest a changing 
pattern and incidence of congenital heart disease 
in various geographic locations [5,6] according to 
racial and ethnic factors[3,7]. Knowledge of the 
epidemiology of congenital heart disease is the 
basis on which investigative efforts will emerge 
to identify the causes of cardiac dysmorpho-
genesis and afford opportunities to prevent 
them[8]. 
     There is no information about the prevalence 
rate of congenital heart diseases in Gorgan. 
Therefore, the objective of this study was to 
estimate the pattern and the prevalence rate of 
congenital heart diseases in a referral hospital in 
Gorgan, which is the capital city of Golestan 
province in northern Iran. 
Subjects and Methods  
This longitudinal and hospital-based 
investigation was undertaken on all 11,739 live 
births to identify all newborns with congenital 
heart malformation, born between January 1, 
2007 and December 31, 2008, in Dezyani - a 
teaching hospital and a referral center which is 
the main site for about 80% of deliveries in 
Gorgan, Iran. Dezyani is a referral hospital with 
an annual rate of more than 6000 deliveries, 
accounting for 20% of annual births in Golestan 
province. The largest portion (80%) of deliveries 
in the city and other deliveries (20%) in Gorgan 
city are carried out in four private hospitals and 
in hospitals of Ministry of Labor. Golestan 
province has a population of about 1.8 million 
and covers an area of about 20460 kilometer 
square. Patients are usually from moderate to 
low socioeconomic class families. 
     Live newborns delivered in this hospital 
during the investigation were examined and 
screened for CHD and follow-up for six months. 
Different types of CHDs considered for the 
present investigation are: Ventricular Septal 
Defect (VSD), Atrial Septal Defect (ASD), 
Tetralogy of Fallot (TOF), Patent Ductus 
Arteriosus (PDA), Pulmonary Stenosis (PS), 
Transposition of Great Arteries (TGA), Total 
Anomalous Pulmonary Venous Connection 
(TAPVC), Partial Anomalous Pulmonary Venous 
Connection (PAPVC), Pulmonary Artesia (PA), 
Single Ventricle (SV), Ebstein Anomaly (EA) and 
Complex CHDs (various types of CHDs existing 
together including rare type of CHDs).  
     Clinical examination, 2D echocardiography 
and color Doppler and cardiac catheterization 
were considered as definitive tools for diagnosis 
of CHD. Variables recorded included the date of 
birth, sex, type of malformation and the presence 
of other congenital malformations. The total 
number of live figures of every year was 
recorded. 
     The ethical committee has approved the 
study. Descriptive data are presented as 
percentages. Descriptive statistics was 
calculated for CHD prevalence per 1,000 live 
births. The prevalence of CHD is calculated as 
follows: 
Annual rate = CHD cases/total live births. 
Confidence interval (95%CI) for prevalence was 
calculated by binomial exact methods. 
     STATA8/SE statistical package was used for 
statistical analysis. 
Findings 
The overall prevalence of CHD live births during 
this 2-year period was 8. 6/1000 live births. CHD 
was found to be more common in male than 
female births (9.96 versus 7.34 per 1000). The 
risk of CHD in males was 1.35 times more than in 
females (OR=1.35, 95%CI 0.81-2.02 P>0.05). The 
rate of CHD was 4.53 per 1000 in 2007 and 
13.36 per 1000 in 2008. 
     The Pattern and prevalence rate of congenital 
malformations according to sex is depicted in 
Table 1.  
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Table 1: Cardiovascular malformations distribution by sex 
Congenital Heart Disease Male Female 
Atrial Septal Defect (ASD) 18 13 
Ventricular Septal Defect (VSD) 9 1 
Patent Ductus Arteriosus (PDA) 6 9 
VSD & ASD 6 9 
Tetralogy of Fallot 1 1 
Mitral regurgitation 2 0 
ASD and PDA 1 1 
VSD and PDA 1 0 
Tricuspidal regurgitation 1 1 
Pulmonary hypertension 1 0 
Pulmonary stenosis 2 2 
Patent Foramen Ovale (PFO) 1 0 
Tricuspid Regurgitation (TR) and Pulmonary Regurgitation  2 0 
PR and Pulmonary Stenosis (PS) 1 0 
VSD, ASD and PDA 3 1 
PS, TR and VSD 2 0 
Mitral Valve Prolapse 1 0 
Coarctation of the Aorta, PDA and Pulmonary Hypertension 0 1 
 
     ASD was the commonest lesion (2.64 per 
1000), followed by VSD +ASD (1.28 per 1000), 
PDA (1.28 per 1000) and VSD (0. 85 per 1000). 
The rate of ASD in males and females was 3.02 
and 2.26 per1000 respectively. The rate of VSD 
in males was 1.54 and in females 0.17 per 1000 
(P<0.05). PDA and VSD+ASD were found to be 
more common in females than in males (Table1). 
     Parents of 40 (39.6%) babies were related. 39 
(38.6%) couples were first cousins and 1% were 
weakly related. None of the affected newborns 
had a positive family history of birth defects. 
Hypertension, diabetes, thyroids disorder and 
history of stillbirth were found in 1% of mothers.  
     Two (2.6%) newborns with CHD had other 
congenital anomalies; one was Down syndrome, 
the other one had neural tube defect. 
Discussion 
This study was conducted to explore the pattern 
and the prevalence rate of CHD in Gorgan. The 
overall prevalence of CHD during this 2-year 
period was 8.6/1000 live births. 
     There is just one study available from Iran 
which gives the incidence of CHD per 1000 live 
births by Rahim et al, 2008[9]. They reported the 
prevalence of 12.30/1000 live births. Our 
estimation of prevalence cannot be compared to 
this earlier study, because they included all CHDs 
in age groups ranging from 0 to 60 years in 
Khuzestan province of Iran in southwest of the 
country, bordering Iraq and the Persian Gulf. Its 
capital is Ahwaz and covers an area of 63,238 
km2 and population of 4.3 million. Our province 
has racial/ethnic and environmental differences 
with Khuzestan province.  
     In our study the overall prevalence of CHD   
(8.6/1000) is higher than in the findings of Fixler 
in Dallas, USA [3] and of Beqic in Tuzla, Bosnia-
Herzegovina [10], Spain [11], England [12], Finland 
[13], Germany [14], Oman [15], North African Arabs 
[16,17], Thai and Pakistani populations[18,19], but it 
is lower than in Italians [20,21], Qatari [22], and 
Iceland populations [23]. The reported prevalence 
in Indian population tends to be higher than in 
other populations [24].  
     The prevalence and pattern of individual 
congenital heart diseases in North Iran and 
different parts of the world is depicted in Table 
2.   
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Table2: The prevalence of individual congenital heart diseases in per/1000 recorded during 2007-2008 in North 
Iran and different parts of the world 
Author ASD PDA VSD PS TOF VSD+ASD Country 
Present study 2.64 1.28 0.85 0.34 0.17 1.28 North Iran 
Rahim et al[9] 1.95 1.80 1.10 3.60 1.70 - South–West Iran 
Antia[26] 1.42 1.80 2.70 1.23 1.23 - Nigeria 
Kapoor and Gupta[24] 1.89 1.46 2.13 0.32 0.46 0.04 India 
Alabdulgader[25] 1.15 0.86 3.95 0.89 0.42 - Saudi Arabia 
Subramanyan et al[23] 1.44 1.03 2.49 0.88 0.96 - Oman 
Marelli et al[28] 3.89 0.31 4.20 0.5 0.49 - Quebec (Canada) 
Shah et al[29] 0.27 - 3.39 - 0.76 - Dharan (Nepal) 
Yang et al[30] 0.27 1.58 2.27 0.62 0.31 0.08 China 
Fixler et al[3] 0.70 0.53 4.28 0.89 0.35 - Dallas (USA) 
ASD: Atrial Septal Defect /  PDA: Patent Ductus Arteriosus /  VSD: Ventricular Septal Defect / PS: Pulmonary stenosis /                           
TOF: Tetralogy of Fallot 
The differences among these results in different 
parts of the world could be related to the study 
population, type of classification, and various 
selection criteria such as live births and still 
births in the study or methods of diagnosis and 
racial/ethnic differences.  
     The most frequent type of CHD was found to 
be ASD which is in accordance with another 
study in Iran[9] while in other studies [8,10,16,20-23] 
the most frequent type of CHD was VSD. This 
could be due to the severity of defects which 
might have led to the death of patients before 
accessing the medical facilities. This might also 
be due to racial and genetic factors in different 
populations.  
      The prevalence of CHD in North Iran similar 
to other studies in Iceland, Italy and Spain[11,20,23] 
had an upward trend during the period of study 
which might be due to the improvement of 
diagnosis, attention or awareness among the 
medical authorities. Further study is needed to 
explore the exact ethological factors.  
      We found that CHD was more common in 
male births. This finding is not similar to that 
reported in Saudi Arabia[25], and Iceland[23] , 
where the frequency was the same for males and 
females while in Nigeria[26] CHD was found to be 
more common in female births.  
     Also, researchers have pointed out the effect 
of race/ethnicity on CHD prevalence[3,7]. 
Racial/ethnical differences in the prevalence of 
cardiac malformations in utero and at live birth 
may have environmental components, e.g., 
nutritional status and teratogen exposure, in 
addition to genetic factors[27].  
     In our study, associated anomalies were seen 
in 2.2% of cases; this rate was 9.0% 
(extracardiac anomalies) and 8.6% 
(chromosomal anomalies) in Manetti’s study in 
Italy[20], 12.0% (extracardiac anomalies) and 
3.80% (Down's syndrome) in Iceland[23] and 
5.0% in Nigeria[26]. In present study, the 
associated anomalies were CNS anomalies and 
Down syndrome, while in Antia’s study in 
Nigeria it occurred in the alimentary tract.   
     This study had certain limitations. Firstly, we 
cannot state the number of severely ill children 
who died during initial steps of resuscitation 
(before the echocardiography could be 
performed). Secondly, we could not assess the 
fate of very small acyanotic lesions like tiny VSD. 
Conclusion 
The present study shows, for the first time, the 
prevalence and pattern of CHD in Gorgan, a city 
in northern Iran. These findings will help 
establish a database for future studies, which 
will focus on etiology and ethnic disparity of 
CHD in the region. The findings can help to 
establish valuable changes in health policies for 
the improvement of diagnostic and therapeutic 
facilities. 
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